Cosmos Pharmaceutical Corp
TSE:3349
Balance Sheet
Balance Sheet Decomposition
Cosmos Pharmaceutical Corp
Cosmos Pharmaceutical Corp
Balance Sheet
Cosmos Pharmaceutical Corp
| May-2003 | May-2004 | May-2005 | May-2006 | May-2007 | May-2008 | May-2009 | May-2010 | May-2011 | May-2012 | May-2013 | May-2014 | May-2015 | May-2016 | May-2017 | May-2018 | May-2019 | May-2020 | May-2021 | May-2022 | May-2023 | May-2024 | May-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Cash & Cash Equivalents |
2 373
|
2 942
|
6 908
|
9 178
|
6 830
|
10 045
|
14 201
|
16 081
|
18 524
|
19 101
|
15 911
|
21 302
|
18 635
|
27 282
|
27 728
|
21 668
|
19 022
|
52 122
|
55 108
|
37 362
|
45 928
|
52 301
|
57 038
|
|
| Cash Equivalents |
2 373
|
2 942
|
6 908
|
9 178
|
6 830
|
10 045
|
14 201
|
16 081
|
18 524
|
19 101
|
15 911
|
21 302
|
18 635
|
27 282
|
27 728
|
21 668
|
19 022
|
52 122
|
55 108
|
37 362
|
45 928
|
52 301
|
57 038
|
|
| Total Receivables |
521
|
451
|
1 012
|
1 568
|
1 664
|
2 128
|
1 098
|
1 139
|
1 430
|
1 792
|
2 090
|
2 346
|
2 739
|
2 986
|
3 387
|
4 627
|
5 653
|
5 879
|
6 619
|
8 577
|
10 221
|
12 199
|
12 240
|
|
| Accounts Receivables |
38
|
39
|
55
|
51
|
57
|
37
|
33
|
31
|
19
|
24
|
22
|
17
|
25
|
28
|
22
|
91
|
398
|
108
|
100
|
198
|
452
|
637
|
761
|
|
| Other Receivables |
483
|
412
|
957
|
1 517
|
1 607
|
2 091
|
1 065
|
1 108
|
1 411
|
1 768
|
2 068
|
2 329
|
2 714
|
2 958
|
3 365
|
4 536
|
5 255
|
5 771
|
6 519
|
8 379
|
9 769
|
11 562
|
11 479
|
|
| Inventory |
4 379
|
5 503
|
8 113
|
11 687
|
13 384
|
14 753
|
16 433
|
19 299
|
19 650
|
24 199
|
27 532
|
31 261
|
34 863
|
38 227
|
40 038
|
48 749
|
53 289
|
53 560
|
60 549
|
66 363
|
77 479
|
86 173
|
92 323
|
|
| Other Current Assets |
271
|
460
|
570
|
854
|
972
|
1 388
|
1 369
|
1 421
|
1 631
|
1 803
|
1 890
|
2 188
|
2 185
|
2 410
|
2 596
|
2 281
|
2 421
|
2 589
|
2 849
|
3 169
|
3 457
|
3 660
|
4 021
|
|
| Total Current Assets |
7 544
|
9 356
|
16 605
|
23 287
|
22 850
|
28 314
|
33 101
|
37 940
|
41 235
|
46 895
|
47 423
|
57 097
|
58 422
|
70 905
|
73 749
|
77 325
|
80 385
|
114 150
|
125 125
|
115 471
|
137 085
|
154 333
|
165 622
|
|
| PP&E Net |
3 073
|
4 384
|
6 533
|
8 167
|
13 007
|
14 581
|
18 993
|
21 572
|
27 236
|
36 820
|
51 942
|
69 147
|
93 772
|
114 463
|
134 450
|
153 976
|
172 816
|
185 374
|
195 131
|
225 286
|
259 464
|
295 798
|
331 125
|
|
| PP&E Gross |
3 073
|
4 384
|
6 533
|
8 167
|
13 007
|
14 581
|
18 993
|
21 572
|
27 236
|
36 820
|
51 942
|
69 147
|
93 772
|
114 463
|
134 450
|
153 976
|
172 816
|
185 374
|
195 131
|
225 286
|
259 464
|
295 798
|
331 125
|
|
| Accumulated Depreciation |
585
|
843
|
1 198
|
1 820
|
2 633
|
3 643
|
4 929
|
6 606
|
8 942
|
11 712
|
15 280
|
19 170
|
25 539
|
33 726
|
43 215
|
53 347
|
63 335
|
73 865
|
84 359
|
96 695
|
109 906
|
126 322
|
144 359
|
|
| Intangible Assets |
12
|
13
|
14
|
36
|
49
|
77
|
429
|
482
|
640
|
785
|
802
|
679
|
489
|
332
|
215
|
295
|
287
|
268
|
326
|
433
|
547
|
497
|
446
|
|
| Long-Term Investments |
6
|
12
|
11
|
12
|
16
|
16
|
12
|
13
|
13
|
14
|
22
|
22
|
31
|
8
|
4
|
5
|
4
|
5
|
5
|
4
|
4
|
4
|
4
|
|
| Other Long-Term Assets |
2 557
|
3 779
|
4 951
|
6 557
|
8 461
|
11 035
|
12 350
|
13 572
|
14 852
|
14 955
|
15 355
|
15 755
|
16 204
|
16 887
|
17 273
|
19 008
|
20 069
|
20 486
|
20 731
|
21 858
|
23 867
|
25 914
|
27 558
|
|
| Total Assets |
13 192
N/A
|
17 544
+33%
|
28 114
+60%
|
38 059
+35%
|
44 383
+17%
|
54 023
+22%
|
64 885
+20%
|
73 579
+13%
|
83 976
+14%
|
99 469
+18%
|
115 544
+16%
|
142 700
+24%
|
168 918
+18%
|
202 595
+20%
|
225 691
+11%
|
250 609
+11%
|
273 561
+9%
|
320 283
+17%
|
341 318
+7%
|
363 052
+6%
|
420 967
+16%
|
476 546
+13%
|
524 755
+10%
|
|
| Liabilities | ||||||||||||||||||||||||
| Accounts Payable |
7 203
|
7 858
|
12 488
|
15 810
|
17 187
|
23 164
|
28 890
|
31 636
|
37 570
|
46 081
|
54 142
|
66 844
|
70 773
|
82 472
|
91 735
|
105 062
|
110 796
|
136 532
|
133 041
|
139 224
|
161 852
|
179 549
|
177 125
|
|
| Accrued Liabilities |
565
|
812
|
810
|
1 105
|
1 459
|
1 694
|
1 802
|
1 967
|
2 016
|
1 902
|
2 642
|
2 979
|
3 971
|
3 870
|
5 415
|
5 088
|
5 832
|
8 147
|
7 504
|
6 456
|
8 516
|
10 083
|
13 403
|
|
| Short-Term Debt |
768
|
1 157
|
2 054
|
1 849
|
2 412
|
2 732
|
2 549
|
2 825
|
2 246
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
253
|
371
|
511
|
2 437
|
1 715
|
2 247
|
5 395
|
6 569
|
6 270
|
5 029
|
3 177
|
3 092
|
3 095
|
3 056
|
4 485
|
6 512
|
7 938
|
|
| Other Current Liabilities |
1 049
|
1 148
|
1 528
|
2 483
|
2 267
|
2 715
|
3 414
|
4 947
|
5 508
|
7 803
|
7 940
|
9 292
|
9 485
|
10 546
|
10 712
|
11 257
|
13 365
|
14 179
|
15 897
|
13 327
|
17 200
|
17 085
|
22 214
|
|
| Total Current Liabilities |
9 584
|
10 974
|
16 880
|
21 247
|
23 325
|
30 305
|
36 908
|
41 746
|
47 851
|
58 223
|
66 439
|
81 362
|
89 624
|
103 457
|
114 132
|
126 436
|
133 170
|
161 950
|
159 537
|
162 063
|
192 053
|
213 229
|
220 680
|
|
| Long-Term Debt |
2 016
|
4 023
|
4 621
|
2 772
|
4 837
|
5 674
|
7 252
|
6 657
|
4 360
|
2 803
|
1 951
|
4 390
|
11 734
|
20 099
|
15 504
|
12 172
|
10 698
|
9 029
|
7 349
|
6 357
|
13 716
|
27 551
|
42 019
|
|
| Other Liabilities |
374
|
400
|
471
|
531
|
611
|
694
|
734
|
770
|
2 073
|
2 063
|
2 204
|
2 549
|
2 505
|
2 860
|
3 002
|
3 113
|
3 404
|
3 629
|
3 854
|
4 125
|
4 126
|
4 324
|
4 593
|
|
| Total Liabilities |
11 975
N/A
|
15 396
+29%
|
21 973
+43%
|
24 550
+12%
|
28 773
+17%
|
36 673
+27%
|
44 894
+22%
|
49 173
+10%
|
54 284
+10%
|
63 089
+16%
|
70 594
+12%
|
88 301
+25%
|
103 863
+18%
|
126 416
+22%
|
132 638
+5%
|
141 721
+7%
|
147 272
+4%
|
174 608
+19%
|
170 740
-2%
|
172 545
+1%
|
209 895
+22%
|
245 104
+17%
|
267 292
+9%
|
|
| Equity | ||||||||||||||||||||||||
| Common Stock |
242
|
242
|
1 389
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
4 178
|
|
| Retained Earnings |
798
|
1 726
|
2 931
|
4 720
|
6 819
|
8 793
|
11 437
|
15 852
|
21 134
|
27 822
|
36 387
|
45 899
|
56 548
|
67 745
|
84 575
|
100 426
|
117 829
|
137 185
|
162 065
|
181 954
|
202 485
|
222 284
|
248 309
|
|
| Additional Paid In Capital |
178
|
178
|
1 821
|
4 610
|
4 610
|
4 610
|
4 610
|
4 610
|
4 610
|
4 610
|
4 610
|
4 610
|
4 610
|
4 610
|
4 610
|
4 610
|
4 610
|
4 610
|
4 610
|
4 610
|
4 610
|
5 101
|
5 101
|
|
| Unrealized Security Profit/Loss |
0
|
1
|
1
|
1
|
3
|
3
|
1
|
2
|
2
|
3
|
8
|
8
|
15
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
234
|
234
|
234
|
235
|
235
|
235
|
236
|
236
|
0
|
238
|
238
|
238
|
238
|
238
|
241
|
242
|
225
|
227
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
60
|
60
|
119
|
73
|
89
|
91
|
61
|
38
|
5
|
40
|
103
|
101
|
|
| Total Equity |
1 218
N/A
|
2 148
+76%
|
6 141
+186%
|
13 509
+120%
|
15 610
+16%
|
17 350
+11%
|
19 992
+15%
|
24 408
+22%
|
29 689
+22%
|
36 380
+23%
|
44 950
+24%
|
54 399
+21%
|
65 055
+20%
|
76 179
+17%
|
93 053
+22%
|
108 888
+17%
|
126 289
+16%
|
145 675
+15%
|
170 578
+17%
|
190 507
+12%
|
211 072
+11%
|
231 442
+10%
|
257 463
+11%
|
|
| Total Liabilities & Equity |
13 192
N/A
|
17 544
+33%
|
28 114
+60%
|
38 059
+35%
|
44 383
+17%
|
54 023
+22%
|
64 886
+20%
|
73 581
+13%
|
83 973
+14%
|
99 469
+18%
|
115 544
+16%
|
142 700
+24%
|
168 918
+18%
|
202 595
+20%
|
225 691
+11%
|
250 609
+11%
|
273 561
+9%
|
320 283
+17%
|
341 318
+7%
|
363 052
+6%
|
420 967
+16%
|
476 546
+13%
|
524 755
+10%
|
|
| Shares Outstanding | ||||||||||||||||||||||||
| Common Shares Outstanding |
18
|
18
|
18
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
40
|
40
|
40
|
40
|
40
|
40
|
40
|
79
|
79
|
79
|
79
|
|